Hermelin David S 4
4 · KV PHARMACEUTICAL CO /DE/ · Filed Sep 13, 2010
Insider Transaction Report
Form 4
KV PHARMACEUTICAL CO /DE/KVA / KVB
Hermelin David S
DirectorVice PresidentOther
Transactions
- Award
Option to Purchase
2009-01-13+15,000→ 15,000 totalExercise: $2.95Exp: 2019-01-13→ Class A Common Stock (15,000 underlying) - Award
Option to Purchase
2010-09-07+10,000→ 10,000 totalExercise: $1.62Exp: 2020-09-07→ Class A Common Stock (10,000 underlying)
Footnotes (2)
- [F1]The option vested in four equal quarterly installments beginning on March 31, 2009.
- [F2]The option vests in five equal annual installments beginning on September 7, 2011.